Advances in genomic technologies have made it possible to detect and analyze mutations with high precision. Techniques such as next-generation sequencing (NGS), whole-genome sequencing, and targeted gene panels allow researchers and clinicians to identify mutations across the entire genome or within specific sets of genes. These tools are invaluable for diagnosing cancer, predicting outcomes, and tailoring personalized treatment strategies.
